| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1,220.46 million | USD 2,567.40 million | 7.87% | 2023 |
The global Pulmonary Dilation Balloon market size accrued earnings worth approximately USD 1,220.46 Million in 2023 and is predicted to gain revenue of about USD 2,567.40 Million by 2032, is set to record a CAGR of nearly 7.87% over the period from 2024 to 2032
The pulmonary dilation balloon is a method that is used for the pulmonary valve stenosis treatment. A person suffering from the pulmonary valve stenosis has an abnormality or some kind of deformity in or on the pulmonary valve surroundings. This causes slowing down of the blood flow. The functionality of the pulmonary valve is to make the blood flow from the heart to the lungs. In many cases, the pulmonary valve stenosis develops in a person before his birth.
The product CRE™ is a single-use pulmonary balloon dilator that is used for the endoscopic dilation of the strictures of the airway tree. It is designed exclusively and offers gradual, successive dilation of strictures.
The key factors that are contributing to the growth of the pulmonary dilation balloon market are the rise in the number of congenital heart diseases and the early diagnosis of the diseases due to the availability of the better medical facilities. Furthermore, the pulmonary balloon procedure that is minimally invasive is being preferred more than the conventional methods of surgery thus triggering the growth of the market. The success rate is more in the pulmonary dilation balloon procedure and it has fewer complications thus increasing the chances of the growth of the market. The major factors that are hampering the growth of the market are the growing demands from the surgical procedure and in some of the patients, there is involvement of pulmonary valve stenosis complexities thus restricting the use of the pulmonary dilation balloon.
| Report Attributes | Report Details |
|---|---|
| Report Name | Pulmonary Dilation Balloon Market |
| Market Size in 2023 | USD 1,220.46 Million |
| Market Forecast in 2032 | USD 2,567.40 Million |
| Growth Rate | CAGR of 7.87% |
| Number of Pages | 192 |
| Key Companies Covered | Envaste Medical Instruments, Boston Scientific Corporation, Merit Medical Endotek, Creganna Medical, and Others |
| Segments Covered | By Types, By Applications, and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global market for the pulmonary dilation balloon is fragmented into the end-user industry and the geographical regions.
Based on the end-user industry, the global market is segregated into ambulatory surgical centers, hospitals, and clinics.
In the region-wise outlook, the pulmonary dilation balloon market is categorized into North America, Asia Pacific, Eastern Europe, Latin America, the Middle East and Africa, and the Western Europe.
The regions that are having the most developed market for the pulmonary dilation balloon are the North America and Europe. This is mainly owing to the factor that these regions have the presence of the advanced healthcare infrastructure and facilities. In the Asia Pacific region, the market for the pulmonary dilation balloon is experiencing a moderate growth as there is lack of awareness about its usage even though there is an increased number of pulmonary valve stenosis cases in the region. The market is growing at a sluggish rate owing to the lower GDP in the regions such as the Middle East and Africa.
The key market players that are involved in the pulmonary dilation balloon market include
By Types
By Applications
By Region
By Region
FrequentlyAsked Questions
A pulmonary dilation balloon is a medical device used to widen narrowed pulmonary vessels. It helps restore normal blood flow during minimally invasive procedures.
The global pulmonary dilation balloon market is expected to be driven by the Market expansion is driven by rising respiratory disorders, increasing interventional pulmonology procedures, and growing preference for minimally invasive treatment options.
According to study, the global pulmonary dilation balloon market size was worth around USD 1,220.46 Million in 2023 and is predicted to grow to around USD 2,567.40 Million By 2032.
The global pulmonary dilation balloon market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 7.87% during the forecast period from 2024-2032.
The global pulmonary dilation balloon industry is projected to be challenged by Challenges include strict clinical regulations, risk of procedural complications, and high manufacturing precision requirements. Reimbursement pressures affect adoption rates.
The Opportunities include expansion in interventional pulmonology, growing COPD and airway stenosis cases, and minimally invasive treatment demand. Improved balloon materials and imaging guidance support adoption will offer significant growth opportunities in the pulmonary dilation balloon market.
High-strength, compliant materials for precise dilation; low-profile deliverability systems; pressure-feedback and safety control innovations are the emerging trends and innovations impacting the pulmonary dilation balloon market.
The global pulmonary dilation balloon market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global pulmonary dilation balloon market are; Envaste Medical Instruments, Boston Scientific Corporation, Merit Medical Endotek, Creganna Medical, and Others and others.
The report explores crucial aspects of the pulmonary dilation balloon market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients